Tung CS - Search Results

1

Tung CS, Wong KK, Mok SC. Tung CS, et al. Womens Health (Lond). 2008 Jan;4:27-40. doi: 10.2217/17455057.4.1.27. Womens Health (Lond). 2008. PMID: 19072449 Free article. Review.

2

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.

King ER, Tung CS, Tsang YT, Zu Z, Lok GT, Deavers MT, Malpica A, Wolf JK, Lu KH, Birrer MJ, Mok SC, Gershenson DM, Wong KK. King ER, et al. Among authors: tung cs. Am J Surg Pathol. 2011 Jun;35(6):904-12. doi: 10.1097/PAS.0b013e318212ae22. Am J Surg Pathol. 2011. PMID: 21451362 Free PMC article.

3

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.

Tung CS, Mok SC, Tsang YT, Zu Z, Song H, Liu J, Deavers MT, Malpica A, Wolf JK, Lu KH, Gershenson DM, Wong KK. Tung CS, et al. Mod Pathol. 2009 Sep;22(9):1243-50. doi: 10.1038/modpathol.2009.92. Epub 2009 Jun 12. Mod Pathol. 2009. PMID: 19525924 Free PMC article.

4

PAX2 Expression in Ovarian Cancer.

Song H, Kwan SY, Izaguirre DI, Zu Z, Tsang YT, Tung CS, King ER, Mok SC, Gershenson DM, Wong KK. Song H, et al. Among authors: tung cs. Int J Mol Sci. 2013 Mar 15;14(3):6090-105. doi: 10.3390/ijms14036090. Int J Mol Sci. 2013. PMID: 23502471 Free PMC article.

5

Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer.

Fleming ND, Coleman RL, Tung C, Westin SN, Hu W, Sun Y, Bhosale P, Munsell MF, Sood AK. Fleming ND, et al. Gynecol Oncol. 2017 Oct;147(1):41-46. doi: 10.1016/j.ygyno.2017.07.137. Epub 2017 Aug 1. Gynecol Oncol. 2017. PMID: 28774461 Free PMC article. Clinical Trial.

6

Survivors of gynecologic malignancies: impact of treatment on health and well-being.

Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, Frumovitz MM, Lu KH, Bodurka DC. Westin SN, et al. Among authors: tung cs. J Cancer Surviv. 2016 Apr;10(2):261-70. doi: 10.1007/s11764-015-0472-9. Epub 2015 Aug 6. J Cancer Surviv. 2016. PMID: 26245979 Free PMC article.

7

Survival after intestinal perforation: can it be predicted?

Tung CS, Sun CC, Schlumbrecht MP, Meyer LA, Bodurka DC. Tung CS, et al. Gynecol Oncol. 2009 Dec;115(3):349-53. doi: 10.1016/j.ygyno.2009.08.013. Epub 2009 Sep 18. Gynecol Oncol. 2009. PMID: 19765809 Free PMC article.

8

Successful catheter-directed venous thrombolysis in phlegmasia cerulea dolens.

Tung CS, Soliman PT, Wallace MJ, Wolf JK, Bodurka DC. Tung CS, et al. Gynecol Oncol. 2007 Oct;107(1):140-2. doi: 10.1016/j.ygyno.2007.06.011. Epub 2007 Aug 1. Gynecol Oncol. 2007. PMID: 17669477

9

Assessment of sexual activity and dysfunction in medically underserved women with gynecologic cancers.

Bradford A, Fellman B, Urbauer D, Gallegos J, Meaders K, Tung C, Ramondetta L. Bradford A, et al. Gynecol Oncol. 2015 Oct;139(1):134-40. doi: 10.1016/j.ygyno.2015.08.019. Epub 2015 Aug 29. Gynecol Oncol. 2015. PMID: 26325527 Free PMC article.

10

Small bowel perforation 17 months after robotic surgery for endometrial cancer: A case report.

Faro JP, Graybill WS, Tung CS, Jhingran A, Ramirez PT, Schmeler KM. Faro JP, et al. Among authors: tung cs. Gynecol Oncol Case Rep. 2011 Nov 20;2(1):9-10. doi: 10.1016/j.gynor.2011.11.002. eCollection 2011. Gynecol Oncol Case Rep. 2011. PMID: 24371600 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page